Dr Anne Peters discusses updates in the ADA 2026 Standards of Care in Diabetes, focusing on the use of technology.

A so-called implantable insulin delivery device could one day free people with type 1 diabetes from the need for multiple daily injections, scientists say. "Diabetes is a difficult-to-treat condition, ...

“You can think of this as a living medical device that is made from human cells that secrete insulin, along with an electronic life-support system." Reading time 3 minutes MIT scientists might be one ...

One promising approach to treating Type 1 diabetes is implanting pancreatic islet cells that can produce insulin when needed, which can free patients from giving themselves frequent insulin injections ...

Embecta Corp (NASDAQ:EMBC), a manufacturer of disposable insulin pen needles and syringes, is considering a potential sale following a significant drop in its share price since being spun off from ...

The MarketWatch News Department was not involved in the creation of this content. DELRAY BEACH, Fla., June 25, 2025 /PRNewswire/ -- The global Insulin Delivery Device Market, valued at US$32.6 billion ...

Years after initiating a pair of Class I recalls for various models of its MiniMed insulin pumps—one due to a faulty locking component and the other because of cybersecurity issues with a remote ...

SAN DIEGO--(BUSINESS WIRE)-- Tandem Diabetes Care, Inc. (Nasdaq: TNDM) has announced a voluntary medical device correction for select t:slim X2 insulin pumps to ...

Fractyl Health posted new data from its device-based, one-time diabetes treatment, showing its approach not only helped lower average blood sugar but also led to improvements in long-term insulin ...

In brief: Scientists have spent decades trying to find a cure for type 1 diabetes, an autoimmune condition with no known cause. While reprogramming a human body so it stops attacking the pancreatic ...